XML 17 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income $ 11,366 $ 2,494
Adjustments to reconcile net income to net cash provided by operating activities:    
Amortization and depreciation 1,305 1,687
Restricted stock and stock option expense 1,388 1,080
Deferred federal income taxes 2,899 573
Amortization of bond premium and discount, net (4,258) (547)
Net realized investment losses (gains) (847) 1,520
Loss (income) from equity method investments, net of distributions (390) 82
Changes in:    
Premium receivables, net 9,718 14,119
Reinsurance receivables, net 2,775 (1,051)
Funds held by ceding insurers (492) 1,598
Unpaid losses and loss adjustment expenses 3,003 25,116
Unearned premiums (6,222) (27,408)
Ceded balances payable (991) (11,244)
Other assets and liabilities 2,508 (7,386)
Contingent commissions (3,034) (5,044)
Federal income tax payable 5 0
Deferred acquisition costs 2,214 6,540
Prepaid reinsurance premiums 1,729 3,197
Net cash provided by operating activities 22,676 5,326
Cash flows from investing activities:    
Proceeds from sale of fixed maturities 20,759 44,381
Proceeds from maturity of fixed maturities 125,566 17,515
Proceeds from maturity of preferred stock 334 270
Proceeds from other invested assets 4,604 425
Purchases of fixed maturities (168,208) (60,426)
Purchases of equity securities 0 (19)
Net cash provided by (used for) investing activities (16,945) 2,146
Cash flows from financing activities:    
Distributions paid to common shareholders (4,801) (3,919)
Distributions paid to preferred shareholders (110) (110)
Purchases of class A common shares 0 (6,552)
Net cash used for financing activities (4,911) (10,581)
Net change in cash and cash equivalents 820 (3,109)
Cash and cash equivalents at beginning of period 38,037 38,846
Cash and cash equivalents at end of period $ 38,857 $ 35,737